Semaglutide Proposed for Preoperative Use in Bariatric Surgery for BMI ≥60 kg/m² Patients
Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher
Abstract
Semaglutide is proposed as a preoperative intervention for bariatric surgery in patients with BMI ≥60 kg/m², addressing a critical evidence gap in this high-risk cohort.
